Kipp et al. analyzed the mutation statuses in IDH1/2 of 94 cholangiocarcinomas and correlated them with clinicopathological features, revealing that ICCs with IDH1/2 mutations were poorly differentiated. The gene discussed is IDH1; the disease is cholangiocarcinoma.